• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估致幻剂在成瘾治疗中机制疗效的提案。

A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment.

机构信息

Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

出版信息

Am J Drug Alcohol Abuse. 2013 Sep;39(5):291-7. doi: 10.3109/00952990.2013.811513.

DOI:10.3109/00952990.2013.811513
PMID:23968172
Abstract

Current treatments for addiction are frequently ineffective. Hallucinogenic therapy has been indicated as helpful for a range of substance use disorders, yet this approach remains understudied and publicly unavailable. It is nonetheless a promising treatment, which has significant, long-term beneficial effects with single doses and a profile characterized by general safety, low toxicity, and non-addictiveness. However, pharmacological interventions, such as hallucinogens, should not be offered if the same effects (e.g. psychological insights/mystical experiences) and outcomes (e.g. decreased drug use) could be achieved absent pharmacological intervention. To date, there have been no clinical comparisons of drug-induced altered states with non-drug-induced states for addiction treatment. We propose and then outline a clinical trial to address this gap in knowledge. The proposed design would evaluate abstinence outcomes in a population of prescription opioid abusers after exposure to one of three conditions: a drug-induced altered state using psilocybin, a non-drug-induced altered state via hyperventilation (Holotropic Breathwork), and an active placebo with niacin. The outcomes of such a study would reveal important differences in therapeutic potential by discriminating hallucinogen-dependent effects from those psychological effects resulting from altered states.

摘要

目前针对成瘾的治疗方法往往效果不佳。致幻疗法已被证明对多种物质使用障碍有帮助,但这种方法仍研究不足,公众也无法获得。尽管如此,它仍是一种很有前途的治疗方法,单次用药就有显著的、长期的有益效果,且具有总体安全性、低毒性和非成瘾性等特点。然而,如果可以通过非药物干预获得相同的效果(例如心理洞察力/神秘体验)和结果(例如减少药物使用),则不应提供药理学干预,例如致幻剂。迄今为止,还没有关于药物诱导的改变状态与非药物诱导的改变状态对成瘾治疗的临床比较。我们提出并概述了一项临床试验,以填补这一知识空白。拟议的设计将在接受以下三种条件之一的处方类阿片类药物滥用者人群中评估戒断结果:使用裸盖菇素诱导的药物改变状态、通过过度通气诱导的非药物改变状态(Holotropic Breathwork),以及烟酸的活性安慰剂。这样的研究结果将通过区分致幻剂依赖的效果与改变状态产生的心理效果,揭示出治疗潜力的重要差异。

相似文献

1
A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment.评估致幻剂在成瘾治疗中机制疗效的提案。
Am J Drug Alcohol Abuse. 2013 Sep;39(5):291-7. doi: 10.3109/00952990.2013.811513.
2
Psilocybin--summary of knowledge and new perspectives.裸盖菇素——知识总结与新观点
Eur Neuropsychopharmacol. 2014 Mar;24(3):342-56. doi: 10.1016/j.euroneuro.2013.12.006. Epub 2013 Dec 17.
3
Classic hallucinogens in the treatment of addictions.经典致幻剂在成瘾治疗中的应用。
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:250-8. doi: 10.1016/j.pnpbp.2015.03.002. Epub 2015 Mar 14.
4
Psilocybin: Good Trip or Bad Trip.裸盖菇素:好的旅行还是坏的旅行。
Clin Pharmacol Ther. 2017 Oct;102(4):580-584. doi: 10.1002/cpt.697. Epub 2017 May 26.
5
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.急性、亚急性和长期主观效应的裸盖菇素在健康人类:实验研究的 pooled 分析。
J Psychopharmacol. 2011 Nov;25(11):1434-52. doi: 10.1177/0269881110382466. Epub 2010 Sep 20.
6
Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.裸盖菇素引发的神秘体验在烟草成瘾治疗中的应用
Curr Drug Abuse Rev. 2014;7(3):157-64. doi: 10.2174/1874473708666150107121331.
7
Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.裸盖菇素辅助治疗酒精依赖:一项概念验证研究。
J Psychopharmacol. 2015 Mar;29(3):289-99. doi: 10.1177/0269881114565144. Epub 2015 Jan 13.
8
High dose psilocybin is associated with positive subjective effects in healthy volunteers.高剂量裸盖菇素与健康志愿者的积极主观效应有关。
J Psychopharmacol. 2018 Jul;32(7):770-778. doi: 10.1177/0269881118780713. Epub 2018 Jun 27.
9
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.5-羟色胺能致幻剂治疗心境障碍、焦虑症和物质使用障碍的疗效、耐受性和安全性:系统评价的系统评价。
Expert Rev Clin Pharmacol. 2018 Sep;11(9):889-902. doi: 10.1080/17512433.2018.1511424. Epub 2018 Aug 23.
10
[The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].[裸盖菇素对视觉感知和空间定向的影响——神经心理学方法]
Psychiatr Pol. 2013 Nov-Dec;47(6):1157-67.

引用本文的文献

1
Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.迷幻药物试验中的方法学挑战:裸盖菇素治疗难治性重度抑郁症的疗效与安全性(EPIsoDE)——原理与研究设计
Neurosci Appl. 2022 Mar 7;1:100104. doi: 10.1016/j.nsa.2022.100104. eCollection 2022.
2
[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].[精神病学中的致幻剂和解离剂:治疗中的挑战]
Nervenarzt. 2024 Sep;95(9):803-810. doi: 10.1007/s00115-024-01727-0. Epub 2024 Aug 28.
3
The mechanistic divide in psychedelic neuroscience: An unbridgeable gap?
迷幻神经科学中的机械论分歧:无法弥合的鸿沟?
Neurotherapeutics. 2024 Mar;21(2):e00322. doi: 10.1016/j.neurot.2024.e00322. Epub 2024 Jan 25.
4
Interval delivery of 5HT agonists using multilayered polymer films.使用多层聚合物膜递送电激动剂。
J Biomed Mater Res A. 2023 Jun;111(6):790-800. doi: 10.1002/jbm.a.37497. Epub 2023 Jan 6.
5
Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Mushroom via Amino Acid Metabolism Pathways.胱硫醚γ-裂合酶通过氨基酸代谢途径调节蘑菇中裸盖菇素的生物合成。
J Fungi (Basel). 2022 Aug 18;8(8):870. doi: 10.3390/jof8080870.
6
Effects of 5-HT, 5-HT and 5-HT receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.5-羟色胺、5-羟色胺及5-羟色胺受体激动剂和拮抗剂对条件性强化物反应的影响及其被哌甲酯增强的作用
Psychopharmacology (Berl). 2017 Mar;234(5):889-902. doi: 10.1007/s00213-017-4529-5. Epub 2017 Jan 18.
7
An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.一项关于与自然主义迷幻药使用相关的戒烟情况的在线调查。
J Psychopharmacol. 2017 Jul;31(7):841-850. doi: 10.1177/0269881116684335. Epub 2017 Jan 18.
8
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.死藤水、裸盖菇素和麦角酸二乙酰胺(LSD)的抗抑郁、抗焦虑和抗成瘾作用:对过去25年发表的临床试验的系统评价
Ther Adv Psychopharmacol. 2016 Jun;6(3):193-213. doi: 10.1177/2045125316638008. Epub 2016 Mar 18.